300 related articles for article (PubMed ID: 21073737)
1. Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1α and HIF-2α target genes.
Chun SY; Johnson C; Washburn JG; Cruz-Correa MR; Dang DT; Dang LH
Mol Cancer; 2010 Nov; 9():293. PubMed ID: 21073737
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.
Kikuchi H; Pino MS; Zeng M; Shirasawa S; Chung DC
Cancer Res; 2009 Nov; 69(21):8499-506. PubMed ID: 19843849
[TBL] [Abstract][Full Text] [Related]
3. Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.
Bousquet MS; Ma JJ; Ratnayake R; Havre PA; Yao J; Dang NH; Paul VJ; Carney TJ; Dang LH; Luesch H
ACS Chem Biol; 2016 May; 11(5):1322-31. PubMed ID: 26938486
[TBL] [Abstract][Full Text] [Related]
4. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
5. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
6. The role of hypoxia-inducible factor-1α and -2α in androgen insensitive prostate cancer cells.
Jeong CW; Yoon CY; Jeong SJ; Hong SK; Byun SS; Kwak C; Lee SE
Urol Oncol; 2013 Nov; 31(8):1448-56. PubMed ID: 22537539
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signaling.
Santoyo-Ramos P; Likhatcheva M; García-Zepeda EA; Castañeda-Patlán MC; Robles-Flores M
PLoS One; 2014; 9(11):e112580. PubMed ID: 25396735
[TBL] [Abstract][Full Text] [Related]
8. HIF-2alpha deletion promotes Kras-driven lung tumor development.
Mazumdar J; Hickey MM; Pant DK; Durham AC; Sweet-Cordero A; Vachani A; Jacks T; Chodosh LA; Kissil JL; Simon MC; Keith B
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14182-7. PubMed ID: 20660313
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma.
Zhu GQ; Tang YL; Li L; Zheng M; Jiang J; Li XY; Chen SX; Liang XH
Clin Cancer Res; 2010 Oct; 16(19):4732-41. PubMed ID: 20807755
[TBL] [Abstract][Full Text] [Related]
10. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
11. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of Sirt1 in HIF-1α and HIF-2α mediated hypoxic responses.
Yoon H; Shin SH; Shin DH; Chun YS; Park JW
Biochem Biophys Res Commun; 2014 Jan; 444(1):36-43. PubMed ID: 24423936
[TBL] [Abstract][Full Text] [Related]
13. The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.
Koh MY; Lemos R; Liu X; Powis G
Cancer Res; 2011 Jun; 71(11):4015-27. PubMed ID: 21512133
[TBL] [Abstract][Full Text] [Related]
14. HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice.
Hoefflin R; Harlander S; Schäfer S; Metzger P; Kuo F; Schönenberger D; Adlesic M; Peighambari A; Seidel P; Chen CY; Consenza-Contreras M; Jud A; Lahrmann B; Grabe N; Heide D; Uhl FM; Chan TA; Duyster J; Zeiser R; Schell C; Heikenwalder M; Schilling O; Hakimi AA; Boerries M; Frew IJ
Nat Commun; 2020 Aug; 11(1):4111. PubMed ID: 32807776
[TBL] [Abstract][Full Text] [Related]
15. Vitamin C activates pyruvate dehydrogenase (PDH) targeting the mitochondrial tricarboxylic acid (TCA) cycle in hypoxic
Cenigaonandia-Campillo A; Serna-Blasco R; Gómez-Ocabo L; Solanes-Casado S; Baños-Herraiz N; Puerto-Nevado LD; Cañas JA; Aceñero MJ; García-Foncillas J; Aguilera Ó
Theranostics; 2021; 11(8):3595-3606. PubMed ID: 33664850
[No Abstract] [Full Text] [Related]
16. Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment.
Burkitt K; Chun SY; Dang DT; Dang LH
Mol Cancer Ther; 2009 May; 8(5):1148-56. PubMed ID: 19435875
[TBL] [Abstract][Full Text] [Related]
17. Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids.
Menrad H; Werno C; Schmid T; Copanaki E; Deller T; Dehne N; Brüne B
Hepatology; 2010 Jun; 51(6):2183-92. PubMed ID: 20513003
[TBL] [Abstract][Full Text] [Related]
18. Regulation of 18F-FDG accumulation in colorectal cancer cells with mutated KRAS.
Iwamoto M; Kawada K; Nakamoto Y; Itatani Y; Inamoto S; Toda K; Kimura H; Sasazuki T; Shirasawa S; Okuyama H; Inoue M; Hasegawa S; Togashi K; Sakai Y
J Nucl Med; 2014 Dec; 55(12):2038-44. PubMed ID: 25453050
[TBL] [Abstract][Full Text] [Related]
19. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.
Shah T; Krishnamachary B; Wildes F; Mironchik Y; Kakkad SM; Jacob D; Artemov D; Bhujwalla ZM
Oncotarget; 2015 Sep; 6(29):28104-19. PubMed ID: 26305551
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions.
Jóźwiak P; Ciesielski P; Zaczek A; Lipińska A; Pomorski L; Wieczorek M; Bryś M; Forma E; Krześlak A
J Biomed Sci; 2017 Oct; 24(1):83. PubMed ID: 29084538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]